Skip to main
MODV
MODV logo

ModivCare (MODV) Stock Forecast & Price Target

ModivCare (MODV) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 20%
Hold 60%
Sell 0%
Strong Sell 0%

Bulls say

ModivCare Inc. reported a notable increase in the utilization of its non-emergency medical transportation (NEMT) services, rising by 192 basis points to 10.8%, indicating strong demand for its core offerings. The company's personal care segment (PCS) achieved a 3.0% increase in service revenue, with a corresponding rise in revenue per hour, despite a slight decline in total hours. Additionally, the adjusted EBITDA margin improved to 9.4%, benefiting from non-recurring state-based quality incentive payments and reflecting the company's ongoing commitment to operational efficiency and capturing cost savings.

Bears say

ModivCare Inc. is facing significant revenue challenges, particularly within its Non-Emergency Medical Transportation (NEMT) segment, which is projected to experience a top-line decline of approximately 6.7% in 2025 due to a net revenue headwind of $200 million from recent contract attrition. The company reported a decline in adjusted EBITDA for its Remote Patient Monitoring (RPM) segment, which fell to $6.8 million, below expectations and reflecting lower margins of roughly 35.4%. Additionally, the overall NEMT segment saw a slight revenue decline of 0.8% in the latest quarter, coupled with a notable drop in operating margins, which fell around 600 basis points to just over 3% for FY/24, indicating ongoing operational pressures.

ModivCare (MODV) has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 20% recommend Buy, 60% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of ModivCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About ModivCare (MODV) Forecast

Analysts have given ModivCare (MODV) a Buy based on their latest research and market trends.

According to 5 analysts, ModivCare (MODV) has a Buy consensus rating as of Jul 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.70, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.70, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

ModivCare (MODV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.